Toggle Nav
Close
  • Menu
  • Setting

Atovaquone

Catalog No.
B2078
unique naphthoquinone with broad-spectrum antiprotozoal activity
Grouped product items
SizePriceStock Qty
Evaluation Sample
$30.00
In stock
10mg
$40.00
In stock
50mg
$125.00
In stock
For scientific research use only and should not be used for diagnostic or medical purposes.

Tel: +1-832-696-8203

Email: [email protected]

Worldwide Distributors

Background

Atovaquone is a medication used to treat or prevent for pneumocystis pneumonia, toxoplasmosis, malaria, and babesia.

Chemical Properties

StorageStore at -20°C
M.Wt366.84
Cas No.95233-18-4
FormulaC22H19ClO3
Solubilityinsoluble in EtOH; insoluble in H2O; ≥17.03 mg/mL in DMSO
Chemical Name3-(4-(4-chlorophenyl)cyclohexyl)-4-hydroxynaphthalene-1,2-dione
SDFDownload SDF
Canonical SMILESClC1=C([H])C([H])=C(C([H])=C1[H])C2([H])C([H])([H])C([H])([H])C(C(C3=O)=C(C4=C([H])C([H])=C([H])C([H])=C4C3=O)O[H])([H])C([H])([H])C2([H])[H]
Shipping ConditionSmall Molecules with Blue Ice, Modified Nucleotides with Dry Ice.
General tips We do not recommend long-term storage for the solution, please use it up soon.

Protocol

In vitro experiment [1]:

Parasites

B. gibsoni

Preparation method

The solubility of this compound in DMSO is >17.03mg/mL. General tips for obtaining a higher concentration: Please warm the tube at 37 °C for 10 minutes and/or shake it in the ultrasonic bath for a while. Stock solution can be stored below - 20 °C for several months.

Reacting condition

0 ~ 3.2 μM

Applications

The ΣFICs against WT B. gibsoni were 0.93, 0.82, 0.83 and 0.96 for Atovaquone and Proguanil at a ratio of 4:1, 3:2, 2:3 and 1:4, respectively. The ΣFICs against Atovaquone-resistant B. gibsoni were 0.88, 0.60, 0.77 and 0.88 at each ratio. The results implied that Atovaquone synergized the effects of Proguanil on WT and Atovaquone-resistant B. gibsoni.

Animal experiment [1]:

Animal models

Dogs infected with B. gibsoni

Dosage form

17 ~ 25 mg/kg; p.o.

Applications

In B. gibsoni-infected dogs, the combination of Atovaquone and Proguanil alleviated parasitemia. However, all dogs showed relapse of parasitic infection. In addition, some side effects were also observed. Self-limiting vomiting occurred in 2 dogs and hyperphosphatasia occurred in another dog. Mild increases in the alanine aminotransferase levels were confirmed in 2 dogs.

Other notes

Please test the solubility of all compounds indoor, and the actual solubility may slightly differ with the theoretical value. This is caused by an experimental system error and it is normal.

References:

[1]. Iguchi A, Matsuu A, Fujii Y, Ikadai H, Hikasa Y. The in vitro interactions and in vivo efficacy of atovaquone and proguanil against Babesia gibsoni infection in dogs. Vet Parasitol. 2013 Nov 8;197(3-4):527-33.

Quality Control